MRSA

A collaborative, international effort aims to answer tough antimicrobial resistance questions.

New report highlights risks and costs associated with these infections equal to roughly 1 million deaths and $65 billion in the United States.

Data from a pooled analysis of the REVIVE-1 and 2 studies found iclaprim to be non-inferior to vancomycin based on earl clinical response in patients with wound infections.

A new report from the CDC shows substantial progress on the incidence of health care-associated infections in the United States, but there is still more work to be done.

ID Week 2018 was held October 2-7, 2018, in San Francisco, California. The conference featured results of new studies on a variety of infectious disease topics as well as advancements being made in the field. Here are 5 key takeaways from the meeting.

The combination of daptomycin plus fosfomycin was more effective than daptomycin alone for treating patients with MRSA bacteremia.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Investigators find telavancin has potent in vitro activity and low resistance development potential when used against S aureus isolates in patients with cystic fibrosis.

Additional evidence supports the use of oritavancin as a cost-saving outpatient treatment for acute bacterial skin and skin structure infections (ABSSTIs) in patients who would otherwise be admitted to the hospital for therapy.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

A new review examines previous studies and concludes that healthcare professionals could benefit from sensitivity training when dealing with patients who have HAIs.

The results are significant given the ongoing debate regarding the role of contact precautions for the gram-positive bacteria.

Gram-positive multidrug-resistant infections may be managed effectively with a single dose of long-acting lipo­glycopeptide antibiotics in the outpatient setting; however, careful patient selection is important for maximizing the cost-benefit of these relatively expensive drugs.

Alternative agents are often broader spectrum than ß-lactams, subjecting patients to collateral damage and subsequent selection for resistant organisms and Clostridium difficile.

Study suggests that clinicians should perform confirmatory allergy testing on patients with reported penicillin allergies as an important feature of antimicrobial stewardship.

Oritavancin is a useful antimicrobial option to help clinicians manage MRSA infections and other serious GPC infections in patients with cancer, including in those at the end-of-life.

Skin and soft tissue infections appear to be on the decline in the general population, but individuals with HIV have a higher risk.

The FDA seeks a permanent injunction against a company selling unapproved hand sanitizers that claim to be effective against infections from several pathogens.